X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (195) 195
Publication (18) 18
Book / eBook (7) 7
Patent (4) 4
Book Review (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
index medicus (69) 69
oncology (49) 49
cancer (36) 36
female (34) 34
male (31) 31
middle aged (29) 29
cell biology (28) 28
hematology (28) 28
adult (24) 24
animals (24) 24
aged (21) 21
cell line, tumor (21) 21
cell cycle (19) 19
leukemia (18) 18
centrosome - metabolism (16) 16
leukemia, myeloid, acute - genetics (16) 16
aged, 80 and over (14) 14
analysis (14) 14
chromosomal instability (13) 13
centrosome (12) 12
diagnosis (12) 12
mitosis (12) 12
mutation (12) 12
cells (11) 11
proteins (11) 11
aneuploidy (10) 10
antineoplastic agents - pharmacology (10) 10
apoptosis (10) 10
cell line (10) 10
chromosome aberrations (10) 10
leukemia, myeloid, acute - drug therapy (10) 10
research (10) 10
risk factors (10) 10
signal transduction (10) 10
treatment outcome (10) 10
tumors (10) 10
acute myeloid-leukemia (9) 9
cell division (9) 9
chemotherapy (9) 9
health aspects (9) 9
mice (9) 9
prognosis (9) 9
acute myeloid leukemia (8) 8
aml (8) 8
amplification (8) 8
biology (8) 8
bone marrow (8) 8
genomic instability (8) 8
leukemia, myeloid, acute - mortality (8) 8
phosphorylation (8) 8
stem cells (8) 8
young adult (8) 8
aberrations (7) 7
adolescent (7) 7
age factors (7) 7
cell proliferation (7) 7
centrosome - physiology (7) 7
centrosomes (7) 7
clinical trials (7) 7
cycle (7) 7
flow cytometry (7) 7
genetic aspects (7) 7
instability (7) 7
medical prognosis (7) 7
neoplasms - genetics (7) 7
prospective studies (7) 7
protein (7) 7
s-phase (7) 7
stem-cell transplantation (7) 7
transplantation (7) 7
apoptosis - drug effects (6) 6
aurora-a (6) 6
carcinoma (6) 6
care and treatment (6) 6
cell cycle proteins - metabolism (6) 6
centrosome - drug effects (6) 6
checkpoint kinase 1 (6) 6
chromosomes (6) 6
disease-free survival (6) 6
dna damage (6) 6
gene expression (6) 6
hemic and lymphatic diseases (6) 6
kinases (6) 6
medicine & public health (6) 6
multiple myeloma (6) 6
mutations (6) 6
myelodysplastic syndrome (6) 6
neoplasms - pathology (6) 6
studies (6) 6
time factors (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
binding (5) 5
biochemistry & molecular biology (5) 5
bioscience (5) 5
calcium (5) 5
cell (5) 5
centriole (5) 5
centrosome amplification (5) 5
checkpoint (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (3) 3
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Robarts - Stacks (2) 2
Online Resources - Online (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2016, ISBN 3319225812
This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and... 
Medicine | Pathology | Radiology | Oncology
Web Resource
2016, ISBN 9783319225807, 197
This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and... 
Clinical & internal medicine | Oncology | Pathology | Medicine & Public Health | Diagnostic Radiology | Cancer of unknown primary origin
eBook
Nature, ISSN 0028-0836, 04/2005, Volume 434, Issue 7035, pp. 864 - 870
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2010, Volume 16, Issue 2, pp. 198 - 204
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2019, Volume 9, Issue MAY, p. 402
Journal Article